ROUND TABLE ON HEALTH TECHNOLOGY ASSESSMENT TO INTRODUCE BIOHIGHTECH INNOVATION INTO ITALIAN PUBLIC HOSPITALS

/sites/default/files/2021-09/RESEARCH%20FOR%20BIOMED%20TECHNOLOGY%20INNOVATION_low_0.jpg
Guarda
11:30 - 13:00

ROUND TABLE ON HEALTH TECHNOLOGY ASSESSMENT TO INTRODUCE BIOHIGHTECH INNOVATION INTO ITALIAN PUBLIC HOSPITALS

Chair

10:30 am

ing. Fabio Buffolini

Director - Azienda Regionale Coordinamento Salute FVG

Co-Chair

10:40 am

ing. Maurizio Rizzetto

CTO Technical Dept. - Azienda Sanitaria Friuli Venezia Giulia

Speakers

10:50 am

dott. Riccardo Provasi

Head of Antiblastic Drug Unit – Azienda Sanitaria Universitaria Giuliano Isontina

11:00 am

prof. Paolo Baldo

Director – Hospital pharmacy CRO - Aviano

11:10 am

dott.ssa Beatrice Riva

CEO - Chemicare s.r.l.

11:20 am

prof. Antonio D’Avolio

Head of Clinical Pharmacology and Pharmacogenetics Lab -CoQuaLab. T s.r.l. start-up

11:30 am

prof. Carlo Tascini

Director Infectious diseases – University of Udine

11:40 am

dott. Andrea Petronio

CEO - Feature Jam s.r.l.

11:50 am

dott.ssa Mara Tisi (TBD)

Head of Antiblastic Drug Unit – Cremona Hospital